See more : Ameritrans Capital Corp. PFD PRT 9.375% (AMTPQ) Income Statement Analysis – Financial Results
Complete financial analysis of BioRem Inc. (BIRMF) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of BioRem Inc., a leading company in the Industrial – Pollution & Treatment Controls industry within the Industrials sector.
- The Victoria Mills Limited (VICTMILL.BO) Income Statement Analysis – Financial Results
- Surrozen, Inc. (SRZNW) Income Statement Analysis – Financial Results
- Sandoz Group AG (0SAN.L) Income Statement Analysis – Financial Results
- Steel Connect, Inc. (STCN) Income Statement Analysis – Financial Results
- Kerry Group plc (KRYAF) Income Statement Analysis – Financial Results
BioRem Inc. (BIRMF)
Industry: Industrial - Pollution & Treatment Controls
Sector: Industrials
Website: https://www.biorem.biz
About BioRem Inc.
BioRem Inc., a clean technology engineering company, designs, manufactures, distributes, and sells air pollution control systems that are used to eliminate odors, volatile organic compounds (VOCs), and hazardous air pollutants (HAPs). It offers biofilters for the removal of odors, H2S, VOCs, and HAPs; and biotrickling filters for applications of high levels of H2S or other water-soluble VOCs. The company also provides multi-stage systems to remove odors from various municipal/urban wastewater treatment processes; biogas desulfurization systems; dry scrubber adsorption systems; and cannabis odor control systems. In addition, it offers biological processes and testing services; media sampling and analysis; system review and inspections; and media replacements and spare parts. The company operates in Canada, the United States, China, and internationally. BioRem Inc. was founded in 1990 and is headquartered in Puslinch, Canada.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 25.17M | 28.86M | 24.48M | 24.38M | 20.65M | 24.33M | 22.56M | 15.90M | 16.88M | 10.68M | 19.60M | 15.42M | 12.05M | 17.36M | 18.88M | 14.40M | 9.47M | 12.01M | 10.71M | 2.42K | 8.63M |
| Cost of Revenue | 18.14M | 20.10M | 18.24M | 17.36M | 15.79M | 17.95M | 16.29M | 11.79M | 10.88M | 8.45M | 13.73M | 11.92M | 9.18M | 12.28M | 11.29M | 8.63M | 6.13M | 7.88M | 5.97M | 0.00 | 4.87M |
| Gross Profit | 7.02M | 8.76M | 6.24M | 7.02M | 4.86M | 6.38M | 6.27M | 4.11M | 6.00M | 2.23M | 5.87M | 3.50M | 2.87M | 5.08M | 7.59M | 5.77M | 3.34M | 4.13M | 4.74M | 2.42K | 3.76M |
| Gross Profit Ratio | 27.90% | 30.36% | 25.48% | 28.79% | 23.56% | 26.21% | 27.80% | 25.84% | 35.52% | 20.88% | 29.94% | 22.67% | 23.82% | 29.29% | 40.19% | 40.06% | 35.32% | 34.41% | 44.28% | 100.00% | 43.57% |
| Research & Development | 30.44K | 97.12K | 14.22K | 30.51K | 46.53K | 271.52K | 393.97K | 387.28K | 444.36K | 548.00K | 586.56K | 802.56K | 1.07M | 1.76M | 1.19M | 1.03M | 921.34K | 204.65K | 213.98K | 0.00 | 132.66K |
| General & Administrative | 1.63M | 3.20M | 1.82M | 2.80M | 4.10M | 2.85M | 2.14M | 1.37M | 1.80M | 1.69M | 2.20M | 1.74M | 2.85M | 1.31M | 1.39M | 1.42M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Selling & Marketing | 2.28M | 2.58M | 2.10M | 1.96M | 2.03M | 2.06M | 2.16M | 1.88M | 1.91M | 1.55M | 1.85M | 1.60M | 2.62M | 3.56M | 3.62M | 3.32M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 3.91M | 5.79M | 3.91M | 4.77M | 6.13M | 4.91M | 4.31M | 3.25M | 3.71M | 3.24M | 4.04M | 3.34M | 5.46M | 4.87M | 5.01M | 4.74M | 3.82M | 4.25M | 3.49M | 45.14K | 2.00M |
| Other Expenses | 23.52K | 0.00 | 0.00 | -529.04K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -240.62K | -1.96M | -2.91M | -475.17K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Expenses | 3.96M | 5.88M | 3.90M | 4.46M | 6.17M | 5.15M | 4.61M | 3.44M | 3.87M | 3.51M | 4.63M | 4.14M | 6.54M | 7.21M | 6.68M | 6.60M | 5.31M | 5.00M | 4.24M | 45.14K | 2.48M |
| Cost & Expenses | 22.10M | 25.98M | 22.14M | 21.81M | 21.95M | 23.11M | 20.90M | 15.22M | 14.76M | 11.96M | 18.36M | 16.07M | 15.71M | 19.49M | 17.97M | 15.23M | 11.43M | 12.88M | 10.21M | 45.14K | 7.35M |
| Interest Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 1.58K | 10.29K | 0.00 | 0.00 | 0.00 | 0.00 | -83.56K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Expense | 273.44K | 257.18K | 35.86K | 43.71K | 3.32K | 5.06K | 0.00 | 287.94K | 509.19K | 576.26K | 586.99K | 457.39K | 261.99K | 390.06K | 393.23K | 73.92K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Depreciation & Amortization | 382.71K | 350.65K | 343.62K | 354.46K | 208.53K | 50.70K | 35.23K | 50.97K | 121.61K | 360.15K | 408.24K | 522.78K | 556.16K | 585.68K | 476.34K | 543.69K | 566.52K | 551.69K | 532.40K | 0.00 | 32.39K |
| EBITDA | 3.45M | 2.99M | 2.49M | 3.07M | -814.16K | 1.28M | 1.69M | 723.30K | 2.24M | -785.80K | 1.71M | 150.18K | -2.55M | -1.54M | 1.39M | 188.08K | -1.40M | -319.61K | 1.04M | -42.72K | 1.31M |
| EBITDA Ratio | 13.69% | 11.19% | 10.94% | 11.96% | -5.30% | 5.24% | 8.08% | 4.61% | 13.29% | -8.58% | 8.40% | -0.82% | -26.52% | -7.45% | 7.34% | 1.31% | -14.74% | -2.66% | 9.68% | -1,764.60% | 15.20% |
| Operating Income | 3.06M | 2.64M | 2.07M | 2.72M | -1.02M | 1.72M | 1.53M | 824.93K | 2.20M | -1.15M | 1.30M | -372.60K | -2.87M | -1.88M | 910.25K | 219.68K | -1.96M | -871.30K | 505.10K | -42.72K | 1.28M |
| Operating Income Ratio | 12.17% | 9.15% | 8.46% | 11.15% | -4.95% | 7.07% | 6.78% | 5.19% | 13.02% | -10.73% | 6.66% | -2.42% | -23.80% | -10.83% | 4.82% | 1.53% | -20.72% | -7.26% | 4.71% | -1,764.60% | 14.83% |
| Total Other Income/Expenses | -273.44K | -257.18K | -35.86K | -43.71K | -3.32K | -5.06K | 1.58K | -277.65K | -509.19K | -576.26K | -586.99K | -457.39K | -502.61K | -1.96M | -1.41M | -649.21K | -496.96K | 1.63K | 83.79K | 0.00 | -14.87K |
| Income Before Tax | 2.79M | 2.38M | 2.03M | 2.68M | -1.03M | 1.72M | 1.53M | 547.28K | 1.69M | -1.72M | 717.63K | -829.99K | -3.37M | -4.09M | -502.84K | -429.53K | -2.46M | -869.67K | 588.89K | -42.72K | 1.26M |
| Income Before Tax Ratio | 11.08% | 8.26% | 8.31% | 10.97% | -4.97% | 7.05% | 6.78% | 3.44% | 10.00% | -16.12% | 3.66% | -5.38% | -27.97% | -23.57% | -2.66% | -2.98% | -25.97% | -7.24% | 5.50% | -1,764.60% | 14.66% |
| Income Tax Expense | 609.74K | 770.35K | 736.99K | 586.25K | 276.42K | -2.95M | -45.05K | -21.73K | -44.69K | 576.26K | 586.99K | 457.39K | 261.99K | -953.64K | -1.50M | 2.71K | 542.24K | -100.00K | 245.00K | -17.50K | -661.25K |
| Net Income | 2.18M | 1.61M | 1.30M | 2.09M | -1.30M | 4.67M | 1.53M | 547.28K | 1.69M | -1.72M | 717.63K | -829.99K | -3.37M | -3.14M | -502.84K | -432.24K | -3.00M | -769.67K | 343.89K | -25.22K | 1.93M |
| Net Income Ratio | 8.66% | 5.59% | 5.30% | 8.57% | -6.31% | 19.17% | 6.78% | 3.44% | 10.00% | -16.12% | 3.66% | -5.38% | -27.97% | -18.08% | -2.66% | -3.00% | -31.69% | -6.41% | 3.21% | -1,041.76% | 22.32% |
| EPS | 0.13 | 0.10 | 0.04 | 0.05 | -0.03 | 0.12 | 0.04 | 0.04 | 0.13 | -0.13 | 0.06 | -0.07 | -0.26 | -0.26 | -0.04 | -0.04 | -0.25 | -0.07 | 0.03 | -0.06 | 6.40 |
| EPS Diluted | 0.13 | 0.09 | 0.03 | 0.05 | -0.03 | 0.12 | 0.04 | 0.02 | 0.06 | -0.13 | 0.03 | -0.07 | -0.26 | -0.26 | -0.04 | -0.04 | -0.25 | -0.07 | 0.03 | -0.06 | 2.12 |
| Weighted Avg Shares Out | 16.76M | 15.48M | 35.92M | 38.66M | 38.66M | 38.66M | 38.04M | 15.39M | 13.60M | 12.99M | 12.99M | 12.48M | 12.91M | 12.06M | 12.01M | 10.81M | 12.01M | 11.00M | 11.46M | 425.00K | 300.89K |
| Weighted Avg Shares Out (Dil) | 17.11M | 17.55M | 37.41M | 39.51M | 38.66M | 38.98M | 39.05M | 35.43M | 34.24M | 12.99M | 30.81M | 12.48M | 12.91M | 12.06M | 12.01M | 10.81M | 12.01M | 11.00M | 11.46M | 425.00K | 300.89K |
BIOREM Reports Strong First Quarter Financial Results and Continued Growth in Order Backlog
Source: https://incomestatements.info
Category: Stock Reports